Throat Sprays Market Share

North America industry is likely to hold largest revenue share of 30% by 2037, backed by the presence of various major throat sprays manufacturers, a huge number of public awareness campaigns aimed at reducing infectious diseases, and the growing population of elderly people in the region. For instance, the number of adults aged 65 and over had increased by nearly 53 million in 2021, and it is expected to reach 86 million by 2050.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of throat sprays is estimated at USD 543.6 million.

The throat sprays market size was valued at USD 511.2 million in 2024 and is likely to cross USD 840.61 million by 2037, expanding at more than 3.9% CAGR during the forecast period i.e., between 2025-2037. Rising level of air pollution, rise in prevalence of strep throat problem, upsurge in rhinitis, and spike in upper respiratory infections will drive the market growth.

North America industry is likely to hold largest revenue share of 30% by 2037, backed by presence of various major throat sprays manufacturers, a huge number of public awareness campaigns aimed at reducing infectious diseases, and growing population of elderly people in the region.

The major players in the market are Reckitt Benckiser Group PLC, Procter & Gamble Company, Prestige Consumer Healthcare Inc., Purdue Pharma L.P., Marinomed Biotech AG, Biocidin Botanicals, Melcare Biomedical Pty Ltd, Ursatec GmbH, Puressentiel UK Ltd

Throat Sprays Market Share